Retinal precursors and the development of geographic atrophy in age-related macular degeneration

被引:186
作者
Klein, Michael L. [1 ,2 ,3 ]
Ferris, Frederick L., III [4 ]
Armstrong, Jane [3 ,5 ]
Hwang, Thomas S. [1 ,2 ]
Chew, Emily Y. [4 ]
Bressler, Susan B. [6 ]
Chandra, Suresh R. [7 ]
机构
[1] Oregon Hlth & Sci Univ, Macular Degenerat Ctr, Casey Eye Inst, Portland, OR 97239 USA
[2] Legacy Good Samaritan Hosp, Devers Eye Inst, Portland, OR USA
[3] Med Ctr, Portland, OR USA
[4] NEI, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[5] Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Fundus Photograph Reading Ctr, Madison, WI USA
[6] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA
[7] Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Madison, WI USA
关键词
D O I
10.1016/j.ophtha.2007.08.030
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine specific retinal precursor lesions and sequence of events preceding the onset of geographic atrophy (GA) in eyes with age-related macular degeneration (AMD). Design: Retrospective review. Participants: All participants in the Age-Related Eye Disease Study (AREDS) at 2 clinical centers (Devers Eye Institute, Portland, Oregon, and University of Wisconsin, Madison, Wisconsin) in whom GA initially appeared in at least one eye a minimum of 4 years after the baseline study visit. Methods: All stereoscopic fundus photographs taken before the appearance of GA in the involved (study) eye were reviewed. Fundus features at the site of future GA were graded and recorded. Three graders reviewed photographs, with independent grading and adjudication by mutual agreement. Features graded included drusen (classified by size and confluence), focal hyperpigmentation, hypopigmentation, and refractile deposits. The time between first appearance of these features and initial appearance of GA was recorded. Main Outcome Measure: Appearance of GA. Results: Of all AREDS participants at the 2 sites, 95 eyes of 77 developed GA at least 4 years after entrance into the study. Average time from baseline to initial appearance of GA was 6.6 years (range, 4-11). Drusen were found in 100% of eyes at the site of later developing GA, drusen >1 25 mu m in diameter in 96% of eyes, confluent drusen in 94%, hyperpigmentation in 96%, drusen > 250 mu m in 83%, hypopigmentation in 82%, and refractile deposits in 23%. Time from lesion appearance to onset of GA varied by lesion type, ranging from 5.9 years for drusen confluence to 2.5 years for hypopigmentation or refractile deposits. Lesions generally followed a uniform sequence of appearance. Conclusions: By focusing on the location of initial GA appearance and then retrospectively analyzing prior photographs, we were able to identify specific precursor lesions and the most common sequence of events leading to GA formation in eyes with AMD. The progression was usually characterized by large drusen formation and development of hyperpigmentation, followed by regression of drusen, appearance of hypopigmentation, and ultimately development of GA, sometimes preceded by the appearance of refractile deposits.
引用
收藏
页码:1026 / 1031
页数:6
相关论文
共 22 条
[1]   Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration [J].
Avery, RL ;
Pieramici, DJ ;
Rabena, MD ;
Castellarin, AA ;
Nasir, MA ;
Giust, MJ .
OPHTHALMOLOGY, 2006, 113 (03) :363-372
[2]   Classification of fundus autofluorescence patterns in early age-related macular disease [J].
Bindewald, A ;
Bird, AC ;
Dandekar, SS ;
Dolar-Szczasny, J ;
Dreyhaupt, J ;
Fitzke, FW ;
Einbock, W ;
Holz, FG ;
Jorzik, JJ ;
Keilhauer, C ;
Lois, N ;
Mlynski, J ;
Pauleikhoff, D ;
Staurenghi, G ;
Wolf, S .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (09) :3309-3314
[3]  
Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329
[4]  
GASS JDM, 1973, ARCH OPHTHALMOL-CHIC, V90, P206
[5]   Pegaptanib for neovascular age-related macular degeneration [J].
Gragoudas, ES ;
Adamis, AP ;
Cunningham, ET ;
Feinsod, M ;
Guyer, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2805-2816
[6]  
Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051
[7]   Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration [J].
Holz, Frank G. ;
Bindewald-Wittich, Almut ;
Fleckenstein, Monika ;
Dreyhaupt, Jens ;
Scholl, Hendrik P. N. ;
Schmitz-Valckenberg, Steffen .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (03) :463-472
[8]   Fundus autofluorescence in age-related macular degeneration: An epiphenomenon? [J].
Hopkins, Jill ;
Walsh, Alexander ;
Chakravarthy, Usha .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (06) :2269-2271
[9]   Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration [J].
Hwang, John Chopin ;
Chan, Jackie W. K. ;
Chang, Stanley ;
Smith, R. Theodore .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (06) :2655-2661
[10]   A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8 [J].
Kassoff, A ;
Kassoff, J ;
Buehler, J ;
Eglow, M ;
Kaufman, F ;
Mehu, M ;
Kieval, S ;
Mairs, M ;
Graig, B ;
Quattrocchi, A ;
Jones, D ;
Locatelli, J ;
Ruby, A ;
Capone, A ;
Garretson, B ;
Hassan, T ;
Trese, MT ;
Williams, GA ;
Regan, V ;
Manatrey, P ;
Streasick, P ;
Szydlowski, L ;
McIver, F ;
Bridges, C ;
Stanley, C ;
Cumming, K ;
Lewis, B ;
Zajechowski, M ;
Margherio, RR ;
Cox, MS ;
Camille, J ;
Falk, R ;
Siedlak, P ;
Neubert, C ;
Klein, ML ;
Stout, JT ;
O'Malley, A ;
Lauer, AK ;
Robertson, JE ;
Wilson, DJ ;
Beardsley, C ;
Anderson, H ;
Wallace, P ;
Smith, G ;
Howard, S ;
Dreyer, RF ;
Ma, C ;
Chenoweth, RG ;
Zilis, JD ;
Johnson, M .
ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (10) :1417-1436